Paradromics today announced a $33 million Series A funding round led by Prime Movers Lab. Additional investors include Westcott Investment Group, Dolby Family Ventures, and Green Sands Equity. The new funding will help Paradromics launch its first-in-human clinical trial for the Connexus® Direct Data Interface (DDI).

Paradromics is bringing to market a high data-rate brain-computer interface (BCI). The first application of the Connexus® Direct Data Interface is a BCI-enabled assistive communication device for severely motor-impaired people. This technology could revolutionize the treatment of neurological and brain-related conditions ranging from sensory deficits to mood disorders-allowing millions of people to live happier, healthier, and more enriching lives.